mPharma, the Accra-based health technology company co-founded by Ghanaian entrepreneur Gregory Rockson, has secured new strategic funding to accelerate its expansion and deepen access to affordable medicines across West Africa. The investment, provided by Growth Investment Partners (GIP) Ghana Ltd, an SME-focused platform backed by British International Investment, will support the rollout of mPharma’s pharmacy franchise model into Francophone markets, including Togo and Benin.
The deal strengthens mPharma’s ambition to close long-standing gaps in the region’s pharmaceutical supply chain, where inconsistent pricing and frequent stock-outs have limited access to essential medicines. By backing the company’s QualityRx franchise model, GIP is betting on a system designed to stabilise drug availability while reducing costs for patients, particularly those managing chronic conditions.
Founded in 2013 by Rockson alongside Daniel Shoukimas and James Finucane, mPharma has built an asset-light retail network by partnering with independent pharmacies rather than owning stores outright. Its proprietary software platform allows the company to manage pricing, optimise inventory and reduce shortages, giving small pharmacies the tools to operate more efficiently while offering patients more predictable access to medicines.
Within mPharma’s existing network, the impact has been tangible. The company says more than 70 percent of patients report lower medicine prices, while nearly all experience fewer stock-outs. Its chronic care programmes, including a Diabetes Test and Treat initiative, have also delivered clinical results, with the majority of enrolled patients achieving improved blood sugar control within six months.
Rockson said the latest funding would help the company move faster into underserved markets and scale what he described as a proven model. He said the backing “accelerates our mission to close healthcare access gaps across the region”, as mPharma shifts from a Ghana-focused operation to a broader West African platform.
For GIP Ghana, the investment reflects a growing appetite for impact-driven businesses that combine commercial viability with measurable social outcomes. Jacob Kholi, the firm’s chief executive, said GIP supports companies that improve everyday lives while building sustainable growth, adding that healthcare SMEs are central to that strategy.
The partnership also strengthens mPharma’s ties with regional pharmaceutical distributors such as Ubipharm, GAPOB and Laborex, relationships that will be critical as the company navigates regulatory frameworks and logistics in new markets. With patient capital and operational support now in place, mPharma is positioning itself as a leading force in West Africa’s emerging health-tech ecosystem, at a time when demand for reliable and affordable healthcare solutions continues to rise.
